Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: Implications for use of synovial sublining macrophages as a biomarker
Authors:
Open Access
- 29 October 2007
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 56 (11) , 3869-3871
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2006
- A randomized controlled trial with an anti‐CCL2 (anti–monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritisArthritis & Rheumatism, 2006
- Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2005
- Synovial biopsyBest Practice & Research Clinical Rheumatology, 2005
- Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritisArthritis & Rheumatism, 2004
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995